IP Library Granted Patent US 7,026,105
Granted Patent B2
US 7,026,105 · App. 10/731,251 · Granted Apr 11, 2006

Photothermographic materials containing silver halide sensitized with combination of compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,026,105
App. No.
10/731,251
Granted
Apr 11, 2006
Kind
B2
Abstract

Photothermographic materials are designed with increased photospeed by chemical sensitizing the photosensitive silver halide grains with a combination of compounds. A first chemical sensitizer is a specific gold(III)-containing compound and a second chemical sensitizer is a sulfur-containing compound that is a diphenylphosphine sulfide. The molar ratio of the gold (III)-containing compound to the sulfur-containing compound is at least 1:1.

Claims (121)

1. A photothermographic material comprising a support and having on at least one side thereof, one or more imaging layers comprising a binder and in reactive association:

a. photosensitive silver halide grains,

b. a non-photosensitive source of reducible silver ions, and

c. a reducing composition for said reducible silver ions,

wherein said photosensitive silver halide grains have been chemically sensitized with a combination of chemical sensitizers that consists essentially of:

1) a gold (III)-containing compound that is represented by the following Structure GOLD:

Au(III)L′ r Y q   (GOLD)

wherein L′ represents the same or different ligands, each ligand comprising at least one heteroatom that is capable of forming a bond with gold, Y is an anion, r is an integer of from 1 to 8, and q is an integer of from 0 to 3, and

2) a sulfur-containing compound that is a diphenylphosphine sulfide that is represented by the following Structure PS:

wherein Ph 1 and Ph 2 are the same or different phenyl groups, R 1 and R 2 are independently hydrogen or an alkyl or phenyl group, L is a direct bond or a linking group, m is 1 or 2 and when m is 1, R 3 is a monovalent group, and when m is 2, R 3 is a divalent aliphatic linking group having 1 to 20 carbon, nitrogen, oxygen, or sulfur atoms in the chain, and

the molar ratio of said gold(III)-containing compound to said sulfur-containing compound used in the chemical sensitization is at least 1:1.

2. The photothermographic material of claim 1 wherein said one or more imaging layers further comprise a phosphor that is sensitive to X-radiation and is present in an amount of at least 0.1 mole per mole of total silver and the total silver present in said photothermographic material is at least 0.002 mol/m 2 .

3. The photothermographic material of claim 1 wherein said silver halide is chemically sensitized with said gold(III)-containing compound in an amount of from about 10 −8 to about 10 −2 mole per mole of total silver and with said sulfur-containing compound in an amount of from about 10 −6 to about 10 −1 mole per mole of total silver.

4. The photothermographic material of claim 1 wherein L′ represents the same or different ligands that comprise at least one oxygen, nitrogen, sulfur, or phosphorous atom.

5. The photothermographic material of claim 4 wherein L′ is pyridine, bipyridine, terpyridine, P(phenyl) 3 , carboxylate, imine, phenol, mercaptophenol, imidazole, triazole, and dithiooxamide, Y is a halide, r is an integer of from 1 to 3, and q is 3.

6. The photothermographic material of claim 1 wherein said gold(III)-containing compound is one or more of Compounds Au-1 to Au-14.

Compound

Au(III) Complex

Ligand-H (L′—H)

(Au-1)

AuL′ClBr 2

P(phenyl) 3

(Au-2)

AuL′Cl 3

(Au-3)

AuL′Br 2

(Au-4)

AuL′Cl 3

(Au-5)

L′[AuP(phenyl) 3 ] 3

(Au-6)

AuL′Cl 3

(Au-7)

AuH(L′) 2 Cl 2

(Au-8)

AuL′Cl 2

(Au-9)

Au 2 Zn(L′) 8

(Au-10)

AuPF 6 (L′)2

(Au-11)

Au(L′) 2 Br

(Au-12)

AuL′Cl 3

(Au-13)

Au(L′) 2 (ClO 4 ) 3

Diferrocenylphenylphosphine

(Au-14)

AuL′Cl

Glycylglycyl-L-histidine

7. The photothermographic material of claim 1 wherein R 1 and R 2 are both hydrogen or one of them is methyl, L is a direct bond or sulfonyl or carbonyl linking group, m is 1 and R 3 is an alkyl, aryl, or dialkylamino group.

8. The photothermographic material of claim 1 wherein said sulfur-containing compound is one or more of the following diphenylphosphine sulfide compounds PS-1 to PS-19:

9. The photothermographic material of claim 1 wherein said photosensitive silver halide has been chemically sensitized by decomposition of said sulfur-containing compound on or around the grains thereof in an oxidizing environment.

10. The photothermographic material of claim 1 wherein said binder is a hydrophobic binder or a polymeric latex binder, and said non-photosensitive source of reducible silver ions is a silver salt of a fatty acid having from 10 to 30 carbon atoms, or a mixture of said silver salts, at least one of which is silver behenate.

11. The photothermographic material of claim 1 wherein said photosensitive silver halide is chemically sensitized with a mixture of gold-containing compounds, at least 50 mol % of which are gold(III)-containing compounds represented by Structure GOLD.

12. The photothermographic material of claim 1 wherein said photosensitive silver halide is further chemically sensitized with a second sulfur-containing compound other than a Structure PS compound, a tellurium-containing compound, a selenium-containing compound, or a mixture of any of these compounds.

13. The photothermographic material of claim 1 further comprising in one or more of said imaging layers a phosphor that is calcium tungstate (CaWO 4 ), an activated or unactivated lithium stannate, a niobium and/or rare earth activated or unactivated yttrium, lutetium, or gadolinium tantalates, a rare earth-activated or unactivated middle chalcogen phosphor, or a terbium-activated or unactivated lanthanum and lutetium middle chalcogen phosphor.

14. The photothermographic material of claim 1 further comprising a phosphor that is a rare earth oxychalcogenide and halide phosphor represented by the following formula (1):

M′ (w-n) M″ n O w X″  (1)

wherein M′ is at least one of the metals yttrium (Y), lanthanum (La), gadolinium (Gd), or lutetium (Lm), M″ is at least one of the rare earth metals dysprosium (Dy), erbium (Er), europium (Eu), holmium (Ho), neodymium (Nd), praseodymium (Pr), samarium (Sm), tantalum (Ta), terbium (in), thulium (Tm), or ytterbium (Yb), X″ is a middle chalcogen (5, Se, or Te) or halogen, n is 0.002 to 0.2, and w is 1 when X″ is halogen or 2 when X″ is a middle chalcogen.

15. The photothermographic material of claim 1 further comprising a phosphor that is the product of firing starting materials comprising optional oxide and a combination of species characterized by the following formula (2):

MFX 1-z I z uM a X a :yA: eQ:tD   (2)

wherein “M” is magnesium (Mg), calcium (Ca), strontium (Sr), or barium (Ba), “F” is fluoride, “X” is chloride (Cl) or bromide (Br), “I” is iodide, M a is sodium (Na), potassium (K), rubidium (Rb), or cesium (Cs), X a is fluoride (F), chloride (Cl), bromide (Br), or iodide (I), “A” is europium (Eu), cerium (Ce), samarium (Sm), or terbium (Tb), “Q” is BeO, MgO, CaO, SrO, BaO, ZnO, Al 2 O 3 , La 2 O 3 , In 2 O 3 , SiO 2 , TiO 2 , ZrO 2 , GeO 2 , SnO 2 , Nb 2 O 5 , Ta 2 O 5 , or ThO 2 , “D” is vanadium (V), chromium (Cr), manganese (Mn), iron (Fe), cobalt (Co), or nickel (Ni), “z” is 0 to 1, “u” is from 0 to 1, “y” is from 1×10 −4 to 0.1, “e” is from 0 to 1, and “t” is from 0 to 0.01.

16. The photothermographic material of claim 1 further comprising a phosphor that is a divalent alkaline earth metal fluorohalide phosphors characterized by the following formula (3):

(Ba 1-a-b-c Mg a Ca b Sr c )FX 1-z I z rM a X a :yA   (3)

wherein “M” is magnesium (Mg), calcium (Ca), strontium (Sr), or barium (Ba), “F” is fluoride, “X” is chloride (Cl) or bromide (Br), “I” is iodide, M a is sodium (Na), potassium (K), rubidium (Rb), or cesium (Cs), X a is fluoride (F), chloride (Cl), bromide (Br), or iodide (I), “A” is europium (Eu), cerium (Ce), samarium (Sm), or terbium (Tb), “z” is 0 to 1, “y” is from 1×10 −4 to 0.1, the sum of a, b and c is from 0 to 4, and r is from 10 −6 to 0.1.

17. The photothermographic material of claim 1 further comprising a phosphor and wherein said photosensitive silver halide and phosphor are in the same imaging layer.

18. The photothermographic material of claim 1 comprising the same or a different imaging layer on both sides of said support.

19. An X-radiation sensitive photothermographic material comprising a support having on at least one side thereof, a photothermographic imaging layer having a dry coating weight of from about 5 to about 200 g/m 2 , and a surface protective layer, said imaging layer comprising a hydrophobic binder and in reactive association:

a. grains of a photosensitive silver bromide or silver iodobromide, or both,

b. a non-photosensitive source of reducible silver ions that includes silver behenate,

c. a reducing composition for said reducible silver ions comprising a hindered phenol or an ascorbic acid, and

d. a phosphor that is sensitive to X-radiation and is present in an amount of from about 0.5 to about 20 mole per mole of total silver, the total silver present in said material being at least 0.002 mol/m 2 ,

said phosphor being one or more of YTaO 4 , YTaO 4 :Nb, Y(Sr)TaO 4 , and Y(Sr)TaO4:Nb,

said silver bromide or silver iodobromide grains having been chemically sensitized with a combination of chemical sensitizers that consists essentially of:

1) one or more of the following gold (III)-containing compounds Au-1 to Au-14:

Compound

Au(III) Complex

Ligand-H (L′-H)

(Au-1)

AuL′ClBr 2

P(phenyl) 3

(Au-2)

AuL′Cl 3

(Au-3)

AuL′Br 2

(Au-4)

AuL′Cl 3

(Au-5)

L′[AuP(phenyl) 3 ] 3

(Au-6)

AuL′Cl 3

(Au-7)

AuH(L′) 2 Cl 2

(Au-8)

AuL′Cl 2

(Au-9)

Au 2 Zn(L′) 8

(Au-10)

AuPF 6 (L′) 2

(Au-11)

Au(L′) 2 Br

(Au-12)

AuL′Cl 3

(Au-13)

Au(L′) 2 (ClO 4 ) 3

Diferrocenylphenylphosphine

(Au-14)

AuL′Cl

Glycylglycyl-L-histidine,

and

2) one or more of the following diphenylphosphine sulfide compounds PS-1 to PS-19:

the molar ratio of said gold(III)-containing compound to said diphenylphosphine sulfide compound used in the chemical sensitization is from about 1:1 to about 1:1.000.

20. The photothermographic material of claim 19 wherein said the same or different imaging layer is disposed on both sides of said support, with a protective layer disposed over each imaging layer.

21. A method for forming a visible image comprising:

A) imagewise exposing the photothermographic material of claim 1 to electromagnetic radiation to form a latent image, and

B) simultaneously or sequentially, heating said exposed photothermographic material to develop said latent image into a visible image.

22. The method of claim 21 wherein said photothermographic material support is transparent, and said method further comprises:

C) positioning said exposed and heat-developed photothermographic material with a visible image therein between a source of imaging radiation and an imageable material that is sensitive to said imaging radiation, and

D) thereafter exposing said imageable material to said imaging radiation through said visible image in said exposed and heat-developed photothermographic material to provide a visible image in said imageable material.

23. The method of claim 21 wherein said photothermographic material is X-radiation sensitive and is exposed to X-radiation to form said latent image.

Assignments (17)
RELEASE OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (061579/0341) Recorded Mar 16, 2026
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: CARESTREAM HEALTH, INC.
Reel/Frame 075100/0653 →
SECURITY INTEREST Recorded Mar 13, 2026
From: CARESTREAM HEALTH, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS ADMINISTRATIVE AGENT
Reel/Frame 075081/0379 →
RELEASE OF SECURITY INTEREST Recorded Oct 14, 2022
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL, LLC; QUANTUM MEDICAL IMAGING, L.L.C.; QUANTUM MEDICAL HOLDINGS, LLC; TROPHY DENTAL INC.
Reel/Frame 061681/0380 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (FIRST LIEN) Recorded Oct 14, 2022
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL LLC; QUANTUM MEDICAL IMAGING, L.L.C.; TROPHY DENTAL INC.
Reel/Frame 061683/0441 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (SECOND LIEN) Recorded Oct 14, 2022
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL LLC; QUANTUM MEDICAL IMAGING, L.L.C.; TROPHY DENTAL INC.
Reel/Frame 061683/0601 →
GRANT OF SECURITY INTEREST IN PATENT RIGHTS - TL Recorded Sep 30, 2022
From: CARESTREAM HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 061579/0341 →
GRANT OF SECURITY INTEREST IN PATENT RIGHTS - ABL Recorded Sep 30, 2022
From: CARESTREAM HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 061579/0301 →
SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 1, 2013
From: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL LLC; QUANTUM MEDICAL IMAGING, L.L.C.; TROPHY DENTAL INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 030724/0154 →
AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT (FIRST LIEN) Recorded Jun 28, 2013
From: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL LLC; QUANTUM MEDICAL IMAGING, L.L.C.; TROPHY DENTAL INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 030711/0648 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (SECOND LIEN) Recorded Mar 13, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.
Reel/Frame 027851/0812 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 12, 2011
From: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL, LLC; QUANTUM MEDICAL IMAGING, L.L.C.; QUANTUM MEDICAL HOLDINGS, LLC; TROPHY DENTAL INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 026269/0411 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (FIRST LIEN) Recorded Apr 4, 2011
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.
Reel/Frame 026069/0012 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2008
From: EASTMAN KODAK COMPANY
To: CARESTREAM HEALTH, INC.
Reel/Frame 020756/0500 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2008
From: EASTMAN KODAK COMPANY
To: CARESTREAM HEALTH, INC.
Reel/Frame 020741/0126 →
FIRST LIEN OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 27, 2007
From: CARESTREAM HEALTH, INC.
To: CREDIT SUISSE, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 019649/0454 →
SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEME Recorded Jul 27, 2007
From: CARESTREAM HEALTH, INC.
To: CREDIT SUISSE, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 019773/0319 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2003
From: SIMPSON, SHARON M.; BURLEVA, LILIA P.; SAKIZADEH, KUMARS
To: EASTMAN KODAK COMPANY
Reel/Frame 014783/0136 →